JENBURPH Stock Chart & Stats
₹1034.40
--
Market closed
₹1034.40
--
Day’s Range― - ―
52-Week Range₹944.00 - ₹1,321.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
₹4.64B
Enterprise Value₹3.76K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)14.1
Beta0.82
Next Earnings
Nov 10, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)13.34
Shares Outstanding4,413,300
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
JENBURPH FAQ
What was Jenburkt Pharmaceuticals Ltd’s price range in the past 12 months?
Jenburkt Pharmaceuticals Ltd lowest stock price was ₹944.00 and its highest was ₹1321.00 in the past 12 months.
What is Jenburkt Pharmaceuticals Ltd’s market cap?
Jenburkt Pharmaceuticals Ltd’s market cap is ₹4.64B.
When is Jenburkt Pharmaceuticals Ltd’s upcoming earnings report date?
Jenburkt Pharmaceuticals Ltd’s upcoming earnings report date is Nov 10, 2026 which is in 74 days.
How were Jenburkt Pharmaceuticals Ltd’s earnings last quarter?
Jenburkt Pharmaceuticals Ltd released its earnings results on Aug 06, 2026. The company reported ₹13.336 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Jenburkt Pharmaceuticals Ltd overvalued?
According to Wall Street analysts Jenburkt Pharmaceuticals Ltd’s price is currently Overvalued.
Does Jenburkt Pharmaceuticals Ltd pay dividends?
Jenburkt Pharmaceuticals Ltd does not currently pay dividends.
What is Jenburkt Pharmaceuticals Ltd’s EPS estimate?
Jenburkt Pharmaceuticals Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Jenburkt Pharmaceuticals Ltd have?
Jenburkt Pharmaceuticals Ltd has 4,413,300 shares outstanding.
What happened to Jenburkt Pharmaceuticals Ltd’s price movement after its last earnings report?
Jenburkt Pharmaceuticals Ltd reported an EPS of ₹13.336 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.272%.
Which hedge fund is a major shareholder of Jenburkt Pharmaceuticals Ltd?
Currently, no hedge funds are holding shares in IN:JENBURPH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology